Data / Form D filings / VR1 Corp
VR1 Corp: Form D filings
VR1 Corp, a pharmaceuticals company in New York, NY, filed 6 Form D notices with the SEC between 2012 and 2014. The latest, on September 16, 2014, reports $900,279 sold of a $930,290 offering to 7 investors.
Find out what VR1 Corp does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 68 EAST 131ST STREET, SUITE 307, New York, NY, 10037
- Phone
- (212) 368-2500
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2012
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1561045
The full lists. Form D filings in New York: 4,357 rows, $123.57, or the new rows each week for $19 a month. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Sep 16, 2014 | New notice | $930,290 | $900,279 | $30,011 | 7 | Aug 19, 2014 | sec.gov |
| May 13, 2014 | Amendment | $335,000 | $335,000 | $0 | 10 | Oct 18, 2013 | sec.gov |
| Dec 19, 2013 | Amendment | $150,000 | $150,000 | $0 | 7 | Oct 18, 2013 | sec.gov |
| Oct 28, 2013 | New notice | $63,000 | $63,000 | $0 | 3 | Oct 18, 2013 | sec.gov |
| Jul 1, 2013 | New notice | $530,000 | $530,000 | $0 | 6 | Jun 14, 2013 | sec.gov |
| Nov 7, 2012 | New notice | $624,000 | $624,000 | $0 | 6 | Nov 6, 2012 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Anjan Chatterjee | Executive Officer, Director | |
| Michele Harris | Executive Officer, Director |
Other pharmaceuticals companies in New York that filed recently
- NBO Pharma Inc. $238,000 · Nov 9, 2026
- Pierrepont Therapeutics, Inc. $2.4 million · Sep 22, 2026
Every Form D from the week of Sep 15, 2014 · All recent filings in New York · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what VR1 Corp reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.